CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025
CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.